Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | FULC Fulcrum Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $3.76 -0.3% | $15.06 -2.0% |
| StockIQ Score | 44D Weak Risk: Medium | 36F Weak Risk: Medium |
| Technical | 34F | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 26F | 50C- |
| Fair Value | 55C | 38F |
| News | 56C | 50C- |
| Quality | 58C | 50C- |
| Risk | 48D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Fulcrum Therapeutics (FULC) outperforms Ascentage Pharma (AAPG) in investor confidence and technicals, scoring 49 vs. 37 and 57 vs. 18, respectively. However, AAPG leads in growth potential with a score of 50 compared to FULC’s 26. Both have similar valuation scores, but FULC’s moderate rating suggests slightly stronger overall fundamentals.
